MSM Unify’s strategic partner Pearson’s PTE Academic approved by Canadian Government for Student Direct Stream (SDS) applications

  The recent acceptance of Pearson’s globally recognised English language proficiency test – PTE Academic – by the Immigration, Refugees and Citizenship Canada (IRCC) for Student Direct Stream (SDS) study permit applications was applauded by the higher education sector. Led by global education management group MSM Unify, the sector hailed this as a significant move…

Read More

Strata enters into a strategic partnership with India Land and Global Group, to explore new investment opportunities in Pune

Aims to raise more than Rs. 150 crore in Phase 1 from office space in Pune ·         The asset is over 120,000 square feet, and it expected to offer 12- 13% IRR and 8-9% entry yield ·         India Land and Global Group are well established Real Estate Developers with interests in Industrial, Retail Malls and…

Read More

Safexpay Launches One-click Checkout to Tackle Cart Abandonment for E-commerce

(Aasaan aims to onboard merchants across all retail segments in the Middle East and India) ·         ‘Aasaan Checkout’ solution to increase conversion rates for Direct-to-Consumer brands and e-commerce marketplaces who do not have their own app ·         The platform offers merchants the potential to significantly increase their conversion rates by up to 30% Safexpay, a…

Read More

Beyond 6000 Puffs, Power Alpha Frees You From the Hassle of Charging

Business Wire India SMOORE has gone from strength to strength with its pioneering Power Alpha solution – a charge-free solution offering over 6,000 puffs and consequently creating a ‘more convenient vaping experience’. Power Alpha hosts an assortment of cutting-edge technologies that addresses annoying issues faced by disposable users – a short battery life and the…

Read More

Biocytogen Pharmaceuticals Enters Into License Agreement With Pheon Therapeutics

Exclusive License Agreement for an Oncological Target Antibody to Develop Best-In-Class ADC Business Wire India Biocytogen Pharmaceuticals (Beijing) Co., Ltd. (“Biocytogen”, HKEX: 02315), a global biotech company focusing on the discovery of novel antibody therapeutics, today announces an antibody license agreement with Pheon Therapeutics (Pheon), a leading Antibody-Drug Conjugate (ADC) specialist developing next generation ADCs…

Read More
Back To Top